Diffuse Large B-Cell Lymphoma – Karyopharm Therapeutics
Relapsed/Refractory International Prognostic Index (R/R‐IPI): An international prognostic calculator for relapsed/refractory diffuse large B‐cell lymphoma - Maurer - 2021 - American Journal of Hematology - Wiley Online Library
Diffuse Large B-Cell Lymphoma Risk Score Calculator: A Tool To Accurat" by Santosh Khanal, Arjun Gampala et al.
Gray Zone Lymphoma (GZL) with Features Intermediate between Classical Hodgkin Lymphoma (cHL) and Diffuse Large B-Cell Lymphoma (DLBCL): A Large Retrospective. - ppt download
IPI APP by SECURE SYSTEM BYTES
Prediction of Prognosis for Patients with Diffuse Large B-Cell Lymphoma Refractory to or in First Relapse After Initial R-CHOP Therapy: A Single-Institution Study | Anticancer Research
The Korean Journal of Internal Medicine
Progression-free survival at 24 months (PFS24) and subsequent outcome for patients with diffuse large B-cell lymphoma (DLBCL) enrolled on randomized clinical trials | Semantic Scholar
Tool for Capturing DLBCL Prognosis: The Revised International Prognostic Index (R-IPI)
Cox univariate and multivariate analyses of prognostic factors of... | Download Scientific Diagram
Frontiers | Development and Validation of a Novel Risk Stratification Model for Cancer-Specific Survival in Diffuse Large B-Cell Lymphoma
Molecular profiling of large B-Cell lymphomas : A retrospective observational pilot study
A modified prognostic model in patients with diffuse large B‑cell lymphoma treated with immunochemotherapy
Progression-free survival at 24 months (PFS24) and subsequent outcome for patients with diffuse large B-cell lymphoma (DLBCL) enrolled on randomized clinical trials - Annals of Oncology
Prephase rituximab/prednisone therapy and aging-related, proinflammatory cytokine milieu in older, vulnerable patients with newly diagnosed diffuse large B-cell lymphoma | Haematologica
Diffuse Large B-Cell Lymphoma Prognosis (R-IPI) | QxMD
R/R International Prognostic Index (R/R‐IPI): An international prognostic calculator for relapsed/refractory diffuse large B
Independent Prognostic Value of Serum Markers in Diffuse Large B-Cell Lymphoma in the Era of the NCCN-IPI in: Journal of the National Comprehensive Cancer Network Volume 13 Issue 12 (2015)
Immunohistochemical Distinction Between Diffuse Large B-Cell... | Download Table
Frontiers | A Novel Prognostic Score Including the CD4/CD8 for AIDS-Related Lymphoma
CNS International Prognostic Index: A Risk Model for CNS Relapse in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP | Journal of Clinical Oncology
Diffuse large B cell lymphoma: Outlook, stages, treatment
Quantitative Radiomics Features in Diffuse Large B-Cell Lymphoma: Does Segmentation Method Matter? | Journal of Nuclear Medicine
A model to predict the prognosis of diffuse large B-cell lymphoma based on ultrasound images | Scientific Reports
Diffuse Large B-cell Lymphoma Prognosis Calculator
